Blood Culture Positive Sample Pretreatment Kit
- UID
- IMP/IVD/2023/000207_f4ab824e31cd8f52bd046e49faefc7dd_21e22cad35bbd96b22620ab09270d35c
- Device class
- Class B
- Brand name
- CLIA
- License holder
- Rapid House
- Approving authority
- CDSCO
- Product information
- This kit is used for cell crushing in positive blood culture medium, separating and enriching of pathogenic bacteria. Combined with the mass spectrometry system, the pure culture of pathogenic microbe can be obtained without subculture again, so as to detect them quickly and accurately
Blood Culture Positive Sample Pretreatment Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_f4ab824e31cd8f52bd046e49faefc7dd_21e22cad35bbd96b22620ab09270d35c. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.